Biolumpivaxin

In February 2025, Biovet (Bharat Biotech’s animal health arm) received approval from the Central Drug Standards Control Organization (CDSCO) for Biolumpivaxin, a vaccine for Lumpy Skin Disease (LSD) in cattle and buffaloes, caused by lumpy skin disease virus (LSDV) of genus Capripoxvirus belonging to the family Poxviridae.

  • It is world’s first DIVA vaccine (Differentiating Infected from Vaccinated Animals).
  • It is single annual dose for cattle/buffaloes aged 3+ months.
  • Developed using LSD virus/Ranchi/2019 strain (from ICAR-National Research Centre on Equines, Hisar).
  • Jointly developed by Indian Council of Agricultural Research (ICAR) and Biovet.

What is DIVA Technology?

  • Uses marker antigens missing in natural infection.
  • Enables accurate detection, ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content

Already a Member? Login here

Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material since 2018 of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Be an Annual Subscriber

Current Affairs